Clinical Trial Nuedexta in Subjects With ALS

NCT01806857 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: Nuedexta
DRUG: Matching Placebo

Sponsor

Center for Neurologic Study, La Jolla, California,

Collaborators

[object Object]
[object Object]